Silhouette ciblée
Natural health product licensed in Canada
- Licence holder
- Distributions Santé Leblanc
- NPN or DIN-HM
- 80029346
- Status
- Active licence
- Licence date
- 1 February 2012
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Extrait de pépins de Vitis vinifera (raisin) Source : Pépin de raisin Potency : 80 mg OPC | 100 mg | Not calculated |
| Ilex paraguariensis Source : Feuille Extraction ratio : 4:1 Dry plant equivalent : 300 mg Potency : 4.5 mg caféine | 75 mg | Not calculated |
| Chamomilla recutita Source : Fleur | 50 mg | Not calculated |
Non-medicinal ingredients
Fructooligosaccharides, Gélatine, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | maximum: 1 Capsule | maximum: 2 days |
Uses authorised in Canada
Aide à soulager les symptômes associés à l'insuffisance veineuse chronique mineure, tel que l'oedème subjectif des jambes, la sensation des jambes lourdes et de fourmillements.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80029346
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.